Graves’ disease is an autoimmune disorder that causes overactivity of the thyroid gland, a condition known as hyperthyroidism. It occurs when the immune system produces antibodies that stimulate the thyroid to produce excessive thyroid hormones, leading to widespread effects on metabolism, cardiovascular function, and multiple organ systems. Graves’ disease is the most common cause of hyperthyroidism and often affects adults between the ages of 30 and 60, with a higher prevalence in women. Early recognition and appropriate management are important to prevent long-term complications involving the heart, eyes, and bones.
Causes
Graves’ disease develops as a result of immune system dysfunction rather than a structural abnormality of the thyroid. Several factors are known to contribute to its development.
- Autoimmune activity: Thyroid-stimulating immunoglobulins bind to thyroid receptors, causing excessive hormone production
- Genetic predisposition: Family history of autoimmune thyroid disease increases risk
- Environmental triggers: Stress, smoking, and certain infections may contribute to disease onset
- Hormonal influences: Fluctuations in immune regulation may explain higher incidence in women
- Associated autoimmune conditions: Individuals with other autoimmune disorders may be at increased risk
The thyroid gland often becomes diffusely enlarged (goiter) as a result of persistent stimulation.
Symptoms
Symptoms reflect the effects of elevated thyroid hormone levels and may develop gradually or progress rapidly. Severity varies between individuals.
- Weight loss despite normal or increased appetite
- Heat intolerance and excessive sweating
- Rapid or irregular heartbeat (palpitations)
- Anxiety, irritability, or tremor
- Fatigue and muscle weakness
- Increased bowel movements
- Enlarged thyroid gland in the neck
Some patients develop Graves’ ophthalmopathy, characterized by eye bulging, dryness, irritation, or double vision. Less commonly, skin changes such as thickening over the shins may occur.
Diagnosis
Diagnosis is based on clinical findings supported by laboratory testing and imaging when needed.
- Blood tests: Elevated thyroid hormones (free thyroxine and triiodothyronine) with suppressed thyroid-stimulating hormone levels
- Thyroid antibody testing: Detection of thyroid-stimulating immunoglobulins confirms autoimmune activity
- Radioactive iodine uptake scan: Demonstrates increased and diffuse uptake in the thyroid gland
- Ultrasound: May be used to evaluate thyroid size, blood flow, or nodules
- Eye evaluation: Recommended when visual symptoms or eye involvement is suspected
Accurate diagnosis is essential to differentiate Graves’ disease from other causes of hyperthyroidism.
Treatment Options
Treatment aims to control hormone overproduction, relieve symptoms, and address associated complications. Management is individualized based on age, symptom severity, comorbidities, and patient preference.
- Antithyroid medications: Reduce thyroid hormone production and may induce remission in some patients
- Beta-blockers: Used to control heart rate, tremor, and anxiety symptoms
- Radioactive iodine therapy: Destroys overactive thyroid tissue, often resulting in hypothyroidism requiring lifelong hormone replacement
- Thyroidectomy: Surgical removal of the thyroid gland is considered when medications are ineffective, contraindicated, or when a large goiter or eye disease is present
- Management of eye disease: May include lubricating drops, steroids, or specialized ophthalmologic care